Physician profile
Kay Cherron Philippe
NPI 1114910650
$1,012.53
in general payments reported to CMS, 2019-2025
16 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.43 · 2020: $69.26 · 2021: $273 · 2022: $133 · 2023: $162 · 2024: $170 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $253.34 | 2020-2022 | |
| Tris Pharma INC | $118.71 | 2021-2024 | Dyanavel Xr |
| Aytu Biopharma, INC. | $105.00 | 2020-2025 | |
| Supernus Pharmaceuticals, INC. | $97.00 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $83.59 | 2023-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $66.37 | 2021-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $62.01 | 2023-2025 | |
| Sanofi Pasteur INC. | $54.62 | 2024-2025 | |
| Neos Therapeutics, LP | $46.69 | 2019-2023 | Cotempla Xr-Odt |
| Collegium Pharmaceutical, INC. | $36.75 | 2025 | Jornay Pm |
| Genentech USA, INC. | $19.30 | 2019 | |
| Cranial Technologies, INC | $18.21 | 2024 | Doc Band |
| Sobi, INC | $17.56 | 2021 | |
| Shire North American Group INC | $14.98 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.87 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $4.53 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Cherron Philippe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.